CompoAtlas

Genacol Optimum Comp

Natural health product licensed in Canada

Licence holder
Genacol Group Inc.
NPN or DIN-HM
80093957
Status
Active licence
Licence date
16 August 2019
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Sulfate de chondroïtine

Source : Bos taurus - cartilage

166.67 milligrammeNot calculated
Sulfate de chondroïtine

Source : Chondroïtin sulfate de sodium

166.67 milligrammeNot calculated
Sulfate de 2-Amino-2-désoxy-D-glucose

Source : Exosquelette de crabe

500 milligrammeNot calculated
Sulfate de 2-Amino-2-désoxy-D-glucose

Source : Exosquelette de crevette

500 milligrammeNot calculated
Sulfate de 2-Amino-2-désoxy-D-glucose

Source : Chlorure de potassium

500 milligrammeNot calculated

Non-medicinal ingredients

Croscarmellose de sodium, Stéarate de magnésium, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years3 Comprimé1 Tous les jours

Uses authorised in Canada

A factor in maintaining healthy cartilage and/or joint health. Helps to protect against the deterioration of cartilage. Helps to reduce joint pain associated with osteoarthritis. Helps to relieve (joint) pain associated with osteoarthritis (of the knee).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80093957

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line